(Q46606214)

English

Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

scientific article published on 14 August 2007

Statements

Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit